Physicochemical Properties
| Molecular Formula | C16H11FN2O3 |
| Molecular Weight | 298.27 |
| Exact Mass | 298.075 |
| CAS # | 2375281-44-8 |
| PubChem CID | 139434520 |
| Appearance | White to off-white solid powder |
| LogP | 3.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 22 |
| Complexity | 396 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(O)(=O)C1=CC=CC(C2OC(NC3=CC=CC=C3F)=NC=2)=C1 |
| InChi Key | VGJMPWREFUKMAD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C16H11FN2O3/c17-12-6-1-2-7-13(12)19-16-18-9-14(22-16)10-4-3-5-11(8-10)15(20)21/h1-9H,(H,18,19)(H,20,21) |
| Chemical Name | 3-[2-(2-fluoroanilino)-1,3-oxazol-5-yl]benzoic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | NF-κB 1.58 μM (EC50) |
| ln Vitro | In SH-SY5Y neuroblastoma cells, NF-κΒ activator 2 (compound 61) (1 μM, 6 h) stimulates SOD2 mRNA expression[1]. |
| ln Vivo | In mice, NF-κB activator 2 (1 mg/kg; iv) has an appropriate half-life of 0.96 hours[1]. Comparable half-lives (2.86 hours), oral bioavailability (15.6%), and Cmaxes (92 ng/mL) are shown by NF-κΒ activator 2 (5 mg/kg; po)[1]. |
| References |
[1]. Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS. Eur J Med Chem. 2020 Oct 22;112952. |
Solubility Data
| Solubility (In Vitro) | DMSO :~250 mg/mL (~838.17 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.97 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.3527 mL | 16.7633 mL | 33.5267 mL | |
| 5 mM | 0.6705 mL | 3.3527 mL | 6.7053 mL | |
| 10 mM | 0.3353 mL | 1.6763 mL | 3.3527 mL |